Author(s)

Bodil G. Hornstrup^1*, Pia H. Gjørup², Jost Wessels², Thomas G. Lauridsen^1,2, Erling B. Pedersen¹, Jesper N. Bech^1,2

¹University Clinic in Nephrology and Hypertension, Regional Hospital West Jutland and Aarhus University, Aarhus, Denmark.
²Department of Medicine, Regional Hospital West Jutland, Holstebro, Denmark.

Background: Previous studies of continuous positive airway pressure (CPAP) treatment for obstructive sleep apnoea (OSA) have shown conflicting results on the effect on blood pressure (BP), and patients with chronic kidney disease (CKD) have not been included in these studies. As OSA is a frequent comorbidity in patients with CKD, it is of relevance to evaluate the effect of CPAP treatment on BP in this population. Aim: In this prospective follow-up study, we measured the effect of short term CPAP treatment of moderate-to-severe OSA on brachial and central BP, plasma level of syndecan-1 and vasoactive hormones, renal handling of sodium, subjective sleepiness, and quality of life in patients with impaired renal function. Methods: From December 2015 until March 2017, 25 patients were invited to participate in the study at the University Clinic in Nephrology and Hypertension, Aarhus University and Holstebro Hospital. At baseline and at follow-up after three to four months of CPAP treatment, we performed 24 h brachial and central ambulatory BP measurement, blood sampling measurements of plasma concentrations of syndecan-1, renin, angiotensin II, aldosterone, vasopressin, creatinine, haemoglobin A1c, and cholesterol, cardio respiratory monitoring, 24 h urine collection for measurement of urinary excretion of albumin, aquaporin-2, and epithelial sodium channel, Epworth Sleepiness Scale (ESS), and SF-36 (quality of life). Results: At follow-up, the 17 included patients with mean baseline estimated glomerular filtration rate 66 mL/min/1.73 m² had a significant decrease in systolic office-, 24 h- and daytime-BP (13, 7, and 8 mmHg, respectively, p < 0.05), a non-significant reduction of nocturnal BP (6 mmHg). No changes was measured in frequency of non-dipping or in central 24 h-, day- and nighttime-BP. Renal function remained unchanged, but urinary albumin excretion fell. ESS was unchanged. Quality of life improved. Conclusion: Short-term CPAP treatment of patients with moderate-to-severe OSA and reduced renal function decreased 24 h- and daytime-BP significantly and reduced urinary albumin excretion. Our results underline the importance of treatment of OSA in hypertensive patients with impaired renal function.

Chronic Kidney Disease, Nocturnal Blood Pressure, Obstructive Sleep Apnoea, Central Blood Pressure, Continuous Positive Airway Pressure

Hornstrup, B. , Gjørup, P. , Wessels, J. , Lauridsen, T. , Pedersen, E. and Bech, J. (2019) Changes in Brachial and Central Blood Pressure after Short Term Continuous Positive Airway Pressure Treatment of Patients with Moderate-to-Severe Obstructive Sleep Apnoea and Impaired Renal Function. Open Journal of Nephrology, 9, 1-19. doi: 10.4236/ojneph.2019.91001.